BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 17161256)

  • 1. Protective effects of carvedilol against anthracycline-induced cardiomyopathy.
    Kalay N; Basar E; Ozdogru I; Er O; Cetinkaya Y; Dogan A; Inanc T; Oguzhan A; Eryol NK; Topsakal R; Ergin A
    J Am Coll Cardiol; 2006 Dec; 48(11):2258-62. PubMed ID: 17161256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity.
    Nabati M; Janbabai G; Baghyari S; Esmaili K; Yazdani J
    J Cardiovasc Pharmacol; 2017 May; 69(5):279-285. PubMed ID: 28141699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive role of carvedilol in adriamycin-induced cardiomyopathy.
    Jhorawat R; Kumari S; Varma SC; Rohit MK; Narula N; Suri V; Malhotra P; Jain S
    Indian J Med Res; 2016 Nov; 144(5):725-729. PubMed ID: 28361826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: A prospective randomized controlled study with six-month follow-up.
    Elitok A; Oz F; Cizgici AY; Kilic L; Ciftci R; Sen F; Bugra Z; Mercanoglu F; Oncul A; Oflaz H
    Cardiol J; 2014; 21(5):509-15. PubMed ID: 24142687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E; Kurum T
    Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
    Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R
    Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
    Bergström A; Andersson B; Edner M; Nylander E; Persson H; Dahlström U
    Eur J Heart Fail; 2004 Jun; 6(4):453-61. PubMed ID: 15182771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
    Paraskevaidis I; Farmakis D; Parissis JT; Dodouras T; Filippatos G; Tsiapras D; Kremastinos DT
    J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of carvedilol on angiotensin-converting enzyme activity and renin plasma levels in patients with chronic heart failure.
    Cohen Solal A; Jondeau G; Beauvais F; Berdeaux A
    Eur J Heart Fail; 2004 Jun; 6(4):463-6. PubMed ID: 15182772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
    Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.
    Cardinale D; Colombo A; Lamantia G; Colombo N; Civelli M; De Giacomi G; Rubino M; Veglia F; Fiorentini C; Cipolla CM
    J Am Coll Cardiol; 2010 Jan; 55(3):213-20. PubMed ID: 20117401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Enalapril on Preventing Anthracycline-Induced Cardiomyopathy.
    Janbabai G; Nabati M; Faghihinia M; Azizi S; Borhani S; Yazdani J
    Cardiovasc Toxicol; 2017 Apr; 17(2):130-139. PubMed ID: 27003392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
    Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
    Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.
    Bajcetic M; Kokic Nikolic A; Djukic M; Kosutic J; Mitrovic J; Mijalkovic D; Jovanovic I; Simeunovic S; Spasic MB; Samardzic R
    Clin Ther; 2008 Apr; 30(4):702-14. PubMed ID: 18498919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five cases of anthracycline-induced cardiomyopathy effectively treated with carvedilol.
    Mukai Y; Yoshida T; Nakaike R; Mukai N; Iwato K; Kyo T; Kaseda S
    Intern Med; 2004 Nov; 43(11):1087-8. PubMed ID: 15609710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
    Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
    Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S
    Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.